Related Experiment Video
Updated: Jun 6, 2025

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
The Use of APC/C Antagonists to Promote Mitotic Catastrophe in Cancer Cells
Ammar Mayah1, Raúl Benito Arenas2, Agatha Bastida3
1Oxford Target Therapeutics (OTT), Bioinnovation Hub, Oxford, UK.
Abstract:
The multiprotein subunit E3 ubiquitin ligase Anaphase-Promoting Complex/Cyclosome (APC/C) plays a key role in the control of mitosis progression. APC/C is the ultimate effector of the Spindle Assembly Checkpoint (SAC), the signaling system of higher organisms including the human that monitors the proper attachment of chromosomes to microtubules during cell division. Defects in this process result in genome instability, aneuploidy, premature aging, and cancer. APC/C roles in the SAC require its activation by the protein Cdc20. Interfering with APC/C activation by Cdc20 impairs APC/C substrate recognition, resulting in a delayed mitotic exit and eventually inducing cell death. This may be advantageous for the treatment of cancer and malignancies associated with SAC dysregulation. Here we describe a protocol to interfere with mitotic exit through the use of commercially available (Apcin, proTAME) as well as innovative small molecules we have developed that function as antagonists of APC/C activation by Cdc20. We show that the use of these molecules alone and in combination is effective to promote mitotic catastrophe and suppress cell expansion in 2D and 3D (spheroids) cancer cells of different tissue origin, including breast, cervical, and ovarian cancer.
Insights
Small molecules targeting the Anaphase-Promoting Complex/Cyclosome (APC/C) and its activator Cdc20 can induce mitotic catastrophe. This approach shows promise for treating cancers linked to Spindle Assembly Checkpoint (SAC) dysfunction.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- The Anaphase-Promoting Complex/Cyclosome (APC/C) is a crucial E3 ubiquitin ligase regulating mitosis progression.
- APC/C is the effector of the Spindle Assembly Checkpoint (SAC), ensuring accurate chromosome segregation during cell division.
- Dysfunctional SAC signaling leads to genome instability, aneuploidy, premature aging, and cancer.
Purpose of the Study:
- To investigate the potential of small molecules as antagonists of APC/C activation by Cdc20.
- To evaluate the efficacy of these molecules in inducing mitotic catastrophe and suppressing cancer cell proliferation.
Main Methods:
- Utilized commercially available (Apcin, proTAME) and novel small molecules targeting APC/C-Cdc20 interaction.
- Tested these molecules alone and in combination on various cancer cell lines (breast, cervical, ovarian).
- Assessed effects on cell expansion in 2D cultures and 3D spheroids.
Main Results:
- Small molecules effectively interfered with APC/C activation by Cdc20.
- Inhibition of APC/C-Cdc20 interaction led to delayed mitotic exit and induced mitotic catastrophe.
- Demonstrated suppression of cancer cell expansion in both 2D and 3D models.
Conclusions:
- Targeting APC/C activation by Cdc20 with small molecules is a viable strategy to induce cancer cell death.
- This approach holds potential for therapeutic intervention in cancers associated with SAC dysregulation.
- The developed molecules effectively promote mitotic catastrophe and inhibit cancer cell growth.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Anaphase Promoting Complex
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Drugs that Destabilize Microtubules
Mitogens and the Cell Cycle